NCT05394844Completed
Diabetes Education With Real-time Continuous Glucose Monitoring
Study of a Culturally Tailored Diabetes Education Curriculum With Real-time Continuous Glucose Monitoring in a Latinx Population With Type 2 Diabetes (The CUTDM With CGM Study)
Source: ClinicalTrials.gov · Last updated 1 Dec 2025
Brief summary (registry, in English)
Determine the impact of the Compañeros en Salud (Partners in Health) curriculum in conjunction with RT-CGM on glycemic control in Latinx patients with T2D. Participants will be randomized to receive the Companeros en Salud diabetes self-management education and support (DSMES) intervention with or without RT-CGM
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 120 (actual)
- First submitted
- 19 Apr 2022
- Start date
- 11 Nov 2022
- Primary completion date
- 30 Jul 2024
- Lead sponsor
- University of Washington
- Diseases
- Type 2 diabetes
- NCT number
- NCT05394844
What you commit to
- Study type: Interventional
- Participants enrolled: 120
- From 11 Nov 2022 to the primary completion date, 30 Jul 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Exclusion Criteria.
- Duration of diabetes \>15 years
- Type 1 diabetes or latent autoimmune diabetes
- Current use of prandial insulin
- Any condition that prevents walking at least 1 city block
- History of serious mental illness other than adequately treated depression
- History of bariatric surgery or current participation in a weight management program
- Current diagnosis of cancer or other serious or systemic medical condition
- Significant active cardio- or cerebrovascular disease after review by PI
- Pregnancy
- know history x of of hypoglycemia unawareness
- Unable to read, understand, and sign the Informed Consent Form (ICF) and if applicable, an Authorization to Use and Disclose Protected Health Information form (consistent with Health Insurance Portability and Accountability Act of 1996 \[HIPAA\] legislation), communicate with the investigator, and understand and comply with protocol requirements
Who the study is looking for
- Participants adults 18-60 years old
- Self-identify as Latinx
- Have had a clinical diagnosis of T2D within the last 15 years with or without medication use
- Have an A1C ≥8.0% at screening
- Own or have routine access to a personal device that allows attending educational sessions virtually
- Be physically and cognitively able to use the home CGM monitoring device
- Be willing and able to follow all other study procedures
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Washington Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
| University of Washington Diabetes Institute Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.